Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Laurent, Gilardin"'
Autor:
A. Bourgarit, Y. Tandjaoui-Lambiotte, C. Chauvin, Laurent Gilardin, C. Dubost, M. Vasse, P. Bastard, Anavaj Sakuntabhai, H. Nielly, A. Bousquet, M. Roumier, Jagadeesh Bayry, C. Roth
Publikováno v:
La Revue De Medecine Interne
Introduction La survenue de formes severes ou critiques de COVID-19, avec necessite d’une hospitalisation en reanimation, est associee a la presence d’anticorps anti-Interferon de classe I dans environ 10 % des cas [1] . Ces anticorps identifies
Autor:
Ankit Mahendra, Ivan Peyron, Cécile Dollinger, Laurent Gilardin, Meenu Sharma, Bharath Wootla, Séverine Padiolleau-Lefevre, Alain Friboulet, Didier Boquet, Christophe Legendre, Srinivas V Kaveri, Olivier Thaunat, Sébastien Lacroix-Desmazes
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70731 (2013)
Catalytic antibodies are immunoglobulins endowed with enzymatic activity. Catalytic IgG has been reported in several human autoimmune and inflammatory diseases. In particular, low levels of catalytic IgG have been proposed as a prognostic marker for
Externí odkaz:
https://doaj.org/article/a5d66cc79cb3401e9b2f1c3fbe9e1044
Autor:
Olivier Benveniste, Varun K. Sharma, Maxime Lecerf, Anupama Karnam, Emmanuel Stephen-Victor, Bharat Bhatt, Fabian Käsermann, Veerupaxagouda Patil, Kithiganahalli Narayanaswamy Balaji, Jagadeesh Bayry, Naresh Rambabu, Srini V. Kaveri, Mrinmoy Das, Laurent Gilardin, Patrick Bruneval
Publikováno v:
Cell Death and Disease
Cell Death and Disease, Nature Publishing Group, 2020, ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, 2020, 11 (1), pp.50. ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, Nature Publishing Group, 2020, 11 (1), pp.50. ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, Vol 11, Iss 1, Pp 1-14 (2020)
Cell Death & Disease
Cell Death and Disease, Nature Publishing Group, 2020, ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, 2020, 11 (1), pp.50. ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, Nature Publishing Group, 2020, 11 (1), pp.50. ⟨10.1038/s41419-020-2249-y⟩
Cell Death and Disease, Vol 11, Iss 1, Pp 1-14 (2020)
Cell Death & Disease
Autophagy plays an important role in the regulation of autoimmune and autoinflammatory responses of the immune cells. Defective autophagy process is associated with various autoimmune and inflammatory diseases. Moreover, in many of these diseases, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5aab3fd104a4e542dd1233719db4d27
https://www.hal.inserm.fr/inserm-02455428
https://www.hal.inserm.fr/inserm-02455428
Autor:
Vadim Afanasiev, Karine Viala, Dimitri Psimaras, Cécile Delorme, Andrea Barp, Sophie Bernard, Timothée Lenglet, Laurent Gilardin, Pauline Brice
Publikováno v:
Leukemia & Lymphoma. 60:547-549
Autor:
Aude Collignon, Sophie de Guibert, Elise Toussaint, Loic Ysebaert, Alain Delmer, Fatiha Merabet, David Ghez, Laurent Gilardin, Anne Quinquenel, Damien roos Weil, Eric Durot, Sophie Godet, Vincent Levy, Marguerite Vignon, Jehan Dupuis, Thérèse Aurran, Caroline Dartigeas, Marie-Sarah Dilhuydy, Marie-Christine Béné, Stéphane Leprêtre, Natalia Dmytruk, Haykanush Ohanyan
Publikováno v:
American Journal of Hematology.
Autor:
Inge Pareyn, Linda Desender, Daan Dierickx, Kadri Kangro, Marie Scully, Gestur Vidarsson, Jan Voorberg, Aline Vandenbulcke, Ilaria Mancini, Marie-Agnès Azerad, Karen Vanhoorelbeke, Simon F. De Meyer, Flora Peyvandi, Laurent Gilardin, O. J. H. M. Verhagen, An Sofie Schelpe, Hans Deckmyn, Elien Roose, Chiara Vendramin, Nele Vandeputte
Publikováno v:
Thrombosis and haemostasis, 118(10), 1729-1742. Schattauer GmbH
Thrombosis and Haemostasis
Thrombosis and Haemostasis
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by severe ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency, the presence of anti-ADAMTS13 autoantibodies and an open ADAM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928a0966c2f51a5f457ba2eae6af0b65
https://pure.amc.nl/en/publications/antiadamts13-autoantibodies-against-cryptic-epitopes-in-immunemediated-thrombotic-thrombocytopenic-purpura(7b7fde5c-2c9a-4847-a0a8-15916d09c257).html
https://pure.amc.nl/en/publications/antiadamts13-autoantibodies-against-cryptic-epitopes-in-immunemediated-thrombotic-thrombocytopenic-purpura(7b7fde5c-2c9a-4847-a0a8-15916d09c257).html
Autor:
Jordan D. Dimitrov, Olivier Benveniste, Mohan S. Maddur, Jagadeesh Bayry, Pierre Bruhns, Alain Chevailler, Caroline Galeotti, Emmanuel Stephen-Victor, Anupama Karnam, Laurent Gilardin, Srini V. Kaveri, Mrinmoy Das, Cédric Vonarburg, Sandra Wymann
Publikováno v:
Journal of Allergy and Clinical Immunology. 144:524-535.e8
Background Therapeutic normal IgG or intravenous immunoglobulin (IVIG) exerts anti-inflammatory effects through several mutually nonexclusive mechanisms. Recent data in mouse models of autoimmune disease suggest that IVIG induces IL-4 in basophils by
Autor:
Jordan D. Dimitrov, Sandrine Delignat, Y.C. Lone, Sébastien Lacroix-Desmazes, Yohann Repessé, Srini V. Kaveri, Laurent Gilardin
Publikováno v:
Haemophilia. 20:486-492
The administration of therapeutic factor VIII (FVIII) to treat or prevent haemorrhages in haemophilia A patients results, in up to 30% of the cases, in the development of inhibitory anti-FVIII antibodies. Much debate has taken place on the relevance
Autor:
Laurent Gilardin, Anastas Pashov, Srini V. Kaveri, T. Calvez, B. Maillère, A. Pavlova, Yohann Repessé, Johannes Oldenburg, Sébastien Lacroix-Desmazes
Publikováno v:
Haemophilia. 20:176-184
Summary Forty per cent of haemophilia A (HA) patients have missense mutations in the F8 gene. Yet, all patients with identical mutations are not at the same risk of developing factor VIII (FVIII) inhibitors. In severe HA patients, human leucocyte ant
Autor:
Elise Toussaint, Marie-Sarah Dilhuydy, Vincent Levy, Jehan Dupuis, Sophie de Guibert, Loic Ysebaert, Natalia Dmytruk, David Ghez, Aude Collignon, Laurent Gilardin, Anne Quinquenel, Stéphane Leprêtre, Sophie Godet, Thérèse Aurran, Eric Durot, Marguerite Vignon, Haykanush Ohanyan, Damien Roos-Weil, Fatiha Merabet, Alain Delmer, Caroline Dartigeas
Publikováno v:
Blood. 132:3152-3152
Background Autoimmune cytopenia (AIC) are well-known complications of chronic lymphocytic leukemia, occurring in approximately 4 to 10% of patients. The management of CLL-associated AIC is not consensual and patient with uncontrolled AIC are systemat